Cargando…
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis
BACKGROUND/AIM: In order to define future chemoprevention strategies for adenomas or carcinomas in the pouch of patients with familial adenomatous polyposis (FAP), a 4-weeks intervention with (1) sulindac, (2) inulin/VSL#3, and (3) sulindac/inulin/VSL#3 was performed on 17 patients with FAP in a sin...
Autores principales: | Friederich, Pieter, Verschuur, Jelle, van Heumen, Bjorn W. H., Roelofs, Hennie M. J., Berkhout, Marloes, Nagtegaal, Iris D., van Oijen, Martijn G. H., van Krieken, Johannes H. J. M., Peters, Wilbert H. M., Nagengast, Fokko M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077743/ https://www.ncbi.nlm.nih.gov/pubmed/21243500 http://dx.doi.org/10.1007/s00384-010-1127-y |
Ejemplares similares
-
Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis
por: Friederich, P., et al.
Publicado: (2007) -
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls
por: van Heumen, Bjorn WH, et al.
Publicado: (2013) -
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial
por: van Heumen, Bjorn WH, et al.
Publicado: (2013) -
Over-expression of COX-2 mRNA in colorectal cancer
por: Roelofs, Hennie MJ, et al.
Publicado: (2014) -
Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients
por: Ma, Huiying, et al.
Publicado: (2017)